Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Gerhartz

Showing results (111-120 of 118) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 118 results.
Blood|April 1, 1997
Subclassification of diffuse large B-cell lymphomas according to the Kiel classification: distinction of centroblastic and immunoblastic lymphomas is a significant prognostic risk factorM Engelhard, G Brittinger, D Huhn, et al.
British Journal of Haematology|February 15, 2002
Cyclosporin A combined with vincristine, doxorubicin and dexamethasone (VAD) compared with VAD alone in patients with advanced refractory multiple myeloma: an EORTC-HOVON randomized phase III study (06914)P Sonneveld, S Suciu, P Weijermans, et al.
Onkologie|June 1, 1983
[2d interim evaluation of a chemotherapy study on patients with squamous cell carcinomas of the head-neck area. A comparison of 2 therapy regimens: cis-diamminedichloroplatinum (II) and bleomycin versus methotrexate and vindesine]M Schröder, H W von Heyden, A Scherpe, et al.
Blut|September 1, 1981
Principles and present status of a prospective multicenter study on the clinical relevance of the Kiel classificationG Brittinger, U Schmalhorst, H Bartels, et al.
Deutsche Medizinische Wochenschrift (1946)|March 6, 1970
[Experiences with N-Lost phosphamide esters]P Drings, R Allner, N Brock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Dose-response relationship of complementary radiotherapy following four cycles of combination chemotherapy in intermediate-stage Hodgkin's diseaseM Loeffler, V Diehl, M Pfreundschuh, et al.
Leukemia & Lymphoma|July 28, 2016
Chronic Lymphocytic Leukemia (B-CLL) and Immunocytoma (LP-IC): Clinical and Prognostic Relevance of this DistinctionM Engelhard, G Brittinger, R Heinz, et al.
Seminars in Oncology|May 13, 1998
The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study GroupC Bokemeyer, A Harstrick, J Beyer, et al.
Pageof 12

Showing results (111-120 of 118) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 118 results.
Blood|April 1, 1997
Subclassification of diffuse large B-cell lymphomas according to the Kiel classification: distinction of centroblastic and immunoblastic lymphomas is a significant prognostic risk factorM Engelhard, G Brittinger, D Huhn, et al.
British Journal of Haematology|February 15, 2002
Cyclosporin A combined with vincristine, doxorubicin and dexamethasone (VAD) compared with VAD alone in patients with advanced refractory multiple myeloma: an EORTC-HOVON randomized phase III study (06914)P Sonneveld, S Suciu, P Weijermans, et al.
Onkologie|June 1, 1983
[2d interim evaluation of a chemotherapy study on patients with squamous cell carcinomas of the head-neck area. A comparison of 2 therapy regimens: cis-diamminedichloroplatinum (II) and bleomycin versus methotrexate and vindesine]M Schröder, H W von Heyden, A Scherpe, et al.
Blut|September 1, 1981
Principles and present status of a prospective multicenter study on the clinical relevance of the Kiel classificationG Brittinger, U Schmalhorst, H Bartels, et al.
Deutsche Medizinische Wochenschrift (1946)|March 6, 1970
[Experiences with N-Lost phosphamide esters]P Drings, R Allner, N Brock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Dose-response relationship of complementary radiotherapy following four cycles of combination chemotherapy in intermediate-stage Hodgkin's diseaseM Loeffler, V Diehl, M Pfreundschuh, et al.
Leukemia & Lymphoma|July 28, 2016
Chronic Lymphocytic Leukemia (B-CLL) and Immunocytoma (LP-IC): Clinical and Prognostic Relevance of this DistinctionM Engelhard, G Brittinger, R Heinz, et al.
Seminars in Oncology|May 13, 1998
The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study GroupC Bokemeyer, A Harstrick, J Beyer, et al.
Pageof 12